LIST OF IN-TEXT FIGURES
Figure 1. Study Schema (Phase 1 and Phase 2) .....................................................................................15 Figure 2. Axicabtagene Ciloleucel.........................................................................................................25 Figure 3. Phase 1 Dosing Cohorts and Regimens ..................................................................................27 Figure 4 Axicabtagene Ciloleucel Expansion and Correlations with Response and Adverse Events .....................................................................................................................................48